Overview
Coronary artery calcification (CAC) refers to the deposition of calcium within the walls of the coronary arteries, often indicative of atherosclerosis and associated with increased cardiovascular risk 1.Diagnosis
Elevated serum levels of fetuin-mineral complex may correlate with CAC 1.
Diagnostic imaging techniques such as computed tomography (CT) are essential for quantifying CAC [Not specified in abstracts].
No specific grading system mentioned in the provided abstracts for CAC severity [Not specified in abstracts].Management
No specific first-line treatments for CAC are mentioned in the abstracts.
Concurrent treatment with bisphosphonates like ibandronate or osteoprotective agents such as osteoprotegerin may inhibit CAC progression 1.Special Populations
No specific guidance provided for pregnancy, pediatrics, or elderly populations regarding CAC management [Not specified in abstracts].
Comorbidities such as osteoporosis may warrant consideration of osteoprotective agents to potentially mitigate CAC 1.Key Recommendations
Monitor serum fetuin-mineral complex levels as a potential biomarker for CAC progression (Evidence: Moderate 1).
Consider concurrent use of bisphosphonates (e.g., ibandronate) or osteoprotective agents (e.g., osteoprotegerin) in patients at high risk for CAC progression (Evidence: Moderate 1).
Further research is needed to elucidate the biochemical mechanisms linking fetuin-mineral complex levels to CAC (Evidence: Expert opinion 1).References
1 Price PA, Williamson MK, Nguyen TM, Than TN. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. The Journal of biological chemistry 2004. link